Patient and Public Involvement in Health Economics Modelling Raises the Need for Normative Guidance

被引：0
作者：
Stephanie Harvard
Eric Winsberg
机构：
[1] University of British Columbia (UBC),Faculty of Pharmaceutical Sciences
[2] University of Cambridge,Department of History and Philosophy of Science
[3] University of South Florida,Department of Philosophy
来源：
PharmacoEconomics | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Patient and public involvement in health economics research and health technology assessment has been increasing for some time; however, patient and public involvement in health economics modelling is a more recent development. One reason to advance this type of involvement is to help appropriately manage the social and ethical value judgements that are required throughout model development and interpretation. At the same time, patient and public involvement in health economics modelling raises numerous practical and philosophical issues that invite discussion and debate. Recently, we attended an engagement event which invited patients, members of the public, researchers and decision-makers to discuss some of these issues. One priority that emerged in the discussion was to develop normative guidance for patient and public involvement in health economics modelling. In this article, we reflect on this goal from our own perspective, focusing on why normative guidance is needed and what questions that guidance should answer.
引用
收藏
页码：733 / 740
页数：7
相关论文
共 160 条
  • [31] Hamerlijnck D(2018)OP114 the public’s role in understanding the value of health technologies Int J Technol Assess Health Care 34 43-256
  • [32] Hollander R(2021)An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency Int J Technol Assess Health Care 20 37-743
  • [33] Berglas S(2022)The epistemic risk in representation Kennedy Inst Ethics J 32 1-undefined
  • [34] Jutai L(2020)Model evaluation: an adequacy-for-purpose view Philos Sci 87 457-undefined
  • [35] MacKean G(2021)Patient and public involvement in health technology assessment: update of a systematic review of international experiences Int J Technol Assess Health Care 20 37-undefined
  • [36] Weeks L(2019)“Getting to the table”: changing ideas about public and patient involvement in Canadian drug assessment J Health Polit Policy Law 44 631-undefined
  • [37] Single AN(2022)Patient participation in priority setting: co-existing participant roles Soc Sci Med 294 114713-undefined
  • [38] Facey KM(2021)Deliberative processes by health technology assessment agencies: a reflection on legitimacy, values and patient and public involvement comment on" Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe" Int J Health Policy Manage 10 228-undefined
  • [39] Livingstone H(2019)Ethical challenges related to patient involvement in health technology assessment Int J Technol Assess Health Care 35 253-undefined
  • [40] Silva AS(2012)Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7 Med Decis Mak 32 733-undefined
12345678910